Danyal Haider
Examiner (ID: 6723)
Most Active Art Unit | 4144 |
Art Unit(s) | 4144 |
Total Applications | 1 |
Issued Applications | 0 |
Pending Applications | 0 |
Abandoned Applications | 1 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18877472
[patent_doc_number] => 20240000841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 18/312330
[patent_app_country] => US
[patent_app_date] => 2023-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18312330
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/312330 | LIGAND REGULATED PROTEIN-PROTEIN INTERACTION SYSTEM | May 3, 2023 | Pending |
Array
(
[id] => 19060193
[patent_doc_number] => 11939402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Antifungal peptides, compounds including the same, and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 18/128062
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 8788
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128062
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128062 | Antifungal peptides, compounds including the same, and methods of use thereof | Mar 28, 2023 | Issued |
Array
(
[id] => 18628232
[patent_doc_number] => 20230287085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => COLLAGEN FIBER-BASED INK AND METHODS OF USE FOR BIOPRINTING
[patent_app_type] => utility
[patent_app_number] => 18/173506
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173506
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173506 | COLLAGEN FIBER-BASED INK AND METHODS OF USE FOR BIOPRINTING | Feb 22, 2023 | Pending |
Array
(
[id] => 18879086
[patent_doc_number] => 20240002455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => CHILI PEPPER SEED ISOLATED OLIGOPEPTIDE FTLE AND APPLICATION THEREOF IN PREVENTING OR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/169149
[patent_app_country] => US
[patent_app_date] => 2023-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2916
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169149
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/169149 | Chili pepper seed isolated oligopeptide FTLE and application thereof in preventing or treating cancer | Feb 13, 2023 | Issued |
Array
(
[id] => 18628203
[patent_doc_number] => 20230287052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => PEPTIDE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/159021
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159021
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159021 | PEPTIDE COMPOSITIONS AND METHODS OF USE | Jan 23, 2023 | Pending |
Array
(
[id] => 18725848
[patent_doc_number] => 20230340074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/150983
[patent_app_country] => US
[patent_app_date] => 2023-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18150983
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/150983 | METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS | Jan 5, 2023 | Pending |
Array
(
[id] => 18497392
[patent_doc_number] => 20230220022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => HMGN PARTIAL PEPTIDE AND CANCER THERAPY USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/092737
[patent_app_country] => US
[patent_app_date] => 2023-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15497
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18092737
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/092737 | HMGN partial peptide and cancer therapy using the same | Jan 2, 2023 | Issued |
Array
(
[id] => 18673075
[patent_doc_number] => 20230310547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => USE OF SOLUBLE PRO(RENIN) RECEPTOR TO TREAT METABOLIC DISORDERS AND RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/145730
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145730
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145730 | Use of soluble pro(renin) receptor to treat metabolic disorders and related conditions | Dec 21, 2022 | Issued |
Array
(
[id] => 19151381
[patent_doc_number] => 11976280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => SMAC/Diablo inhibitors useful for treating cancer
[patent_app_type] => utility
[patent_app_number] => 18/063397
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 89
[patent_no_of_words] => 34126
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063397
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063397 | SMAC/Diablo inhibitors useful for treating cancer | Dec 7, 2022 | Issued |
Array
(
[id] => 18829655
[patent_doc_number] => 20230398179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => APPLICATION OF SKELETAL MUSCLE SECRETED FACTOR THBS4 IN PREPARATION OF DRUG FOR IMPROVING SYSTEMIC GLUCOSE AND LIPID METABOLISM
[patent_app_type] => utility
[patent_app_number] => 18/062028
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062028
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062028 | Application of skeletal muscle secreted factor THBS4 in preparation of drug for improving systemic glucose and lipid metabolism | Dec 5, 2022 | Issued |
Array
(
[id] => 19256875
[patent_doc_number] => 12016904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF
[patent_app_type] => utility
[patent_app_number] => 18/062534
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 63330
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062534
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062534 | Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF | Dec 5, 2022 | Issued |
Array
(
[id] => 18692557
[patent_doc_number] => 20230322855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => ANTI-ALLERGIC PEPTIDE AND USE THEREOF FOR IMMUNE REGULATION AND ANTI-ALLERGY
[patent_app_type] => utility
[patent_app_number] => 18/061238
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18061238
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/061238 | ANTI-ALLERGIC PEPTIDE AND USE THEREOF FOR IMMUNE REGULATION AND ANTI-ALLERGY | Dec 1, 2022 | Pending |
Array
(
[id] => 19274435
[patent_doc_number] => 12024546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Peptides and anti-cancer compositions including thereof
[patent_app_type] => utility
[patent_app_number] => 18/070125
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 74
[patent_figures_cnt] => 96
[patent_no_of_words] => 14545
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070125
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070125 | Peptides and anti-cancer compositions including thereof | Nov 27, 2022 | Issued |
Array
(
[id] => 19410591
[patent_doc_number] => 12076383
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
[patent_app_type] => utility
[patent_app_number] => 18/056843
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 26924
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18056843
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/056843 | Compositions and methods for inducing humoral and cellular immunities against tumors and cancer | Nov 17, 2022 | Issued |
Array
(
[id] => 18451625
[patent_doc_number] => 20230192904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/057127
[patent_app_country] => US
[patent_app_date] => 2022-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057127
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057127 | BIFUNCTIONAL CHIMERIC MOLECULES FOR LABELING OF KINASES WITH TARGET BINDING MOIETIES AND METHODS OF USE THEREOF | Nov 17, 2022 | Pending |
Array
(
[id] => 18283964
[patent_doc_number] => 20230099436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => METHOD FOR PREPARING NATURAL BIOACTIVE PEPTIDE TUBULYSIN U
[patent_app_type] => utility
[patent_app_number] => 17/984642
[patent_app_country] => US
[patent_app_date] => 2022-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 492
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984642
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/984642 | Method for preparing natural bioactive peptide Tubulysin U | Nov 9, 2022 | Issued |
Array
(
[id] => 18647849
[patent_doc_number] => 20230293625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Method for treating gingivitis and gingival atrophy and repairing oral mucosa
[patent_app_type] => utility
[patent_app_number] => 18/048025
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048025
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048025 | Method for treating gingivitis and gingival atrophy and repairing oral mucosa | Oct 18, 2022 | Pending |
Array
(
[id] => 18449589
[patent_doc_number] => 20230190865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => VIP Antagonists and Uses in Treating Cancer
[patent_app_type] => utility
[patent_app_number] => 18/047135
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047135
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047135 | VIP Antagonists and Uses in Treating Cancer | Oct 16, 2022 | Pending |
Array
(
[id] => 18322507
[patent_doc_number] => 20230120635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => Peptides and Fragments for Treating Diabetes and Associated Metabolic Diseases
[patent_app_type] => utility
[patent_app_number] => 17/963700
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963700
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/963700 | Peptides and Fragments for Treating Diabetes and Associated Metabolic Diseases | Oct 10, 2022 | Pending |
Array
(
[id] => 18310051
[patent_doc_number] => 20230113951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => SYSTEMS AND METHODS OF TREATING PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 17/964023
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/964023 | SYSTEMS AND METHODS OF TREATING PROSTATE CANCER | Oct 10, 2022 | Pending |